The AI in Life Science Market is anticipated to experience a remarkable compound annual growth rate (CAGR) of around 25% in ...

Sanofi buys a drug from Dren Bio to claim a stake in the emerging field of deep B-cell depletion for autoimmune diseases.

Sanofi has moved ahead with plans to challenge Pfizer and MSD for a piece of the market for pneumococcal vaccines, taking a 21-valent shot licensed from SK Biosciences into phase 3 testing.

The biotech is taking inspiration from cystic fibrosis treatment and applying a similar approach to developing "corrector" ...

Subtle changes in solvent composition control peptide crystal polymorphism, enabling the formation of distinct structures and offering new insights for designing advanced bio-inspired materials.